Student Scientific Association at the Department of Psychology, Faculty of Medicine, Medical University of Lublin, 20-081 Lublin, Poland.
The Critical Care Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
Nutrients. 2023 Aug 11;15(16):3558. doi: 10.3390/nu15163558.
Haematopoietic stem cell transplantation (HSCT) is a treatment option for many haematological conditions in patients of all ages. Nutritional support is important at each stage of treatment, but particular nutritional needs and dictated support occur during the preparatory (conditioning regimen) and post-transplant periods. Patients may require nutritional treatment by the enteral or parenteral route. The quantitative and qualitative composition of meals may change. Vitamin requirements, including vitamin D and vitamin C, might also be different. An adequately composed diet, adapted to the needs of the patient, may influence the occurrence of complications such as graft-versus-host disease (GvHD), gastrointestinal disorders, infections, and reduced survival time. Haematological diseases as well as transplantation can negatively affect the intestinal flora, with negative consequences in the form of mucosal inflammation and disorders of a functional nature. Currently, aspects related to nutrition are crucial in the care of patients after HSCT, and numerous studies, including randomized trials on these aspects, are being conducted. This study serves the critical analysis of current scientific evidence regarding nutritional support for patients after HSCT.
造血干细胞移植(HSCT)是治疗各年龄段患者多种血液疾病的一种选择。在治疗的每个阶段,营养支持都很重要,但在准备阶段(预处理方案)和移植后阶段会出现特殊的营养需求和规定的支持。患者可能需要通过肠内或肠外途径进行营养治疗。膳食的数量和质量组成可能会发生变化。维生素需求,包括维生素 D 和维生素 C,也可能不同。适当组成的饮食,适应患者的需求,可能会影响并发症的发生,如移植物抗宿主病(GvHD)、胃肠道疾病、感染和生存时间缩短。血液疾病和移植都会对肠道菌群产生负面影响,导致黏膜炎症和功能性质的紊乱。目前,HSCT 后患者的营养相关方面至关重要,正在进行许多包括这些方面的随机试验的研究。本研究对 HSCT 后患者营养支持的当前科学证据进行了批判性分析。